Sanjay Kakkar

Sanjay Kakkar, MD, MSc, MPH, is a biotech and medtech entrepreneur with 30 years of experience in multinational, early-stage and high-growth enterprises. He has a track record of building innovative companies in the life sciences industries in Europe, Asia and the U.S. and advancing novel technologies for the improvement of human health. Kakkar was born and raised in the UK and has worked in the UK, Italy, Germany, India and the U.S.

Kakkar holds a medical degree from King's College, University of London, a master's degree in healthcare management from Harvard University, and a master's degree in preventive cardiology from Imperial College. Early in his career, he held R&D roles at Pharmacia (now Pfizer) and Novartis.

Career history

• Chief Executive Officer at Tensive S.r.l. (joined January 2025)
• Chief Executive Officer and Chairman at Tranquis Therapeutics
• Chief Executive Officer at Peptilogics
• Chief Executive Officer at Armetheon
• Co-founder and Chief Executive Officer at Trigen (a biotechnology company focused on cardiovascular diseases, particularly thrombosis and atherosclerosis)
• Founder and Chairman of Jai Medica, a personalized healthcare company focused on heart disease prevention

What Sanjay Kakkar could bring to Tensive: Drawing on his extensive entrepreneurial background scaling biotech and medtech companies across multiple continents, Kakkar brings proven expertise in advancing novel technologies from development through commercialization. His deep experience in building companies in multinational, early-stage and high-growth enterprises positions him to guide Tensive through its critical clinical and regulatory milestones toward market launch of its REGENERA/SOFTAG breast reconstruction platform. His track record in cardiovascular therapeutics and strategic company building should prove instrumental in accelerating Tensive's path to regulatory approval and commercialization in Europe and the U.S.

This is an automatically generated Light profile created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.